FDA: Fungus found at compounding pharmacy matches meningitis outbreak type

The Boston Globe, October 19, 2012
Federal regulators Thursday said they have confirmed the presence of a fungus in an unopened vial of steroids from the troubled Framingham pharmacy at the center of a nationwide meningitis outbreak that matches the type of infection found in most of the sick patients. A release posted on the US Food and Drug Administration website said regulators found fungus known as Exserohilum rostratum in an unopened vial of methylprednisolone acetate from one of the three implicated lots that were shipped by New England Compounding Center to 23 states.

MOST POPULAR

" style="font-family:inherit">Physician's Scathing Remarks Humiliate Patient, Cost Hospital
  • Alternative Staffing Arrangements
  • " style="font-family:inherit">The Perils of Cut-and-Paste Documentation
  • CMS Predictive Readmission Models 'Not Very Good'
  • Alternative Staffing Arrangements
  • Aging Doctors: Time for Mandatory Competency Testing?
  • Evidence-Based Practice and Nursing Research: Avoiding Confusion
  • SPONSORED REPORTS
    SPONSORED HEADLINES

    SIGN UP

    FREE e-Newsletters Join the Council Subscribe to HL magazine

    SPONSORSHIP & ADVERTISING

    100 Winners Circle Suite 300
    Brentwood, TN 37027

    800-727-5257

    About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
    © HealthLeaders Media 2014 a division of BLR All rights reserved.